← back to search

Yuan Xia

Shandong University · CN
Area of research
Hematology · Molecular Biology
Research interest
Research focused on Multiple myeloma and Cancer research, with related work in GPX4, Downregulation and upregulation, Gouty arthritis. Notable publications include 'The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma', 'Changes of Treg/Th17 Ratio in Spleen of Acute Gouty Arthritis Rat Induced by MSU Crystals', and 'ZDHHC5-mediated S-palmitoylation of FAK promotes its membrane localization and epithelial-mesenchymal transition in glioma'.
h-index
citations
211
works
10
NIH funding
primary concept
email

Recent publications

LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1
Biochemical Pharmacology 2025cited by 4position: middledoi
Preclinical evaluation of TIGIT as a target to enhance efficacy and mitigate T cell exhaustion in multiple myeloma following BCMA-CAR-T therapy
Cell Death and Disease 2025cited by 2position: firstdoi
ZDHHC5-mediated S-palmitoylation of FAK promotes its membrane localization and epithelial-mesenchymal transition in glioma
Cell Communication and Signaling 2024cited by 30position: middledoi
Mesenchymal stem cell infusion for enhancing hematopoietic recovery and addressing cytopenias in CAR-T cell therapy
Stem Cell Research & Therapy 2024cited by 7position: firstdoi
The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma
Cell Death and Disease 2023cited by 79position: middledoi
High-risk multiple myeloma predicted by circulating plasma cells and its genetic characteristics
Frontiers in Oncology 2023cited by 10position: firstdoi
Single-cell transcriptomic atlas throughout anti-BCMA CAR-T therapy in patients with multiple myeloma
Frontiers in Immunology 2023cited by 8position: firstdoi
Characteristics and prognostic value of extramedullary chromosomal abnormalities in extramedullary myeloma
Chinese Medical Journal 2022cited by 9position: firstdoi
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study
Blood Cancer Journal 2022cited by 9position: middledoi
Changes of Treg/Th17 Ratio in Spleen of Acute Gouty Arthritis Rat Induced by MSU Crystals
Inflammation 2018cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lijuan Chen · China National Nuclear Corporation5 papers (2022–2025)Jianyong Li · Central South University3 papers (2022–2024)Na Shen · Nantong University3 papers (2023–2025)Xuxing Shen · Nanjing Medical University3 papers (2023–2025)Yuanyuan Jin · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2023–2023)Qinglin Shi · Nanjing Medical University2 papers (2022–2023)Lei Fan · Nanjing University of Chinese Medicine2 papers (2024–2025)Zhangjie Wang · Shandong University2 papers (2023–2024)Run Zhang · South China Agricultural University2 papers (2022–2023)Yiping Wang · The University of Sydney1 papers (2018–2018)Yang Wang · Nantong University1 papers (2024–2024)Yang Wang · Shandong University of Traditional Chinese Medicine1 papers (2023–2023)Yu Shi · Chongqing University1 papers (2022–2022)Yang Liu · Hebei GEO University1 papers (2025–2025)Lu Yu · Shanghai Medical College of Fudan University1 papers (2024–2024)Yang� Yang · Army Medical University1 papers (2024–2024)Hongbo Li · The First Affiliated Hospital, Sun Yat-sen University1 papers (2023–2023)Xiaomei Li · University of Science and Technology of China1 papers (2018–2018)Wenhao Zhang · Northeast Normal University1 papers (2024–2024)Zhicheng Wang · Nantong University1 papers (2024–2024)